
The new JNC Compendium, Cardiac Amyloidosis: Pathophysiology, Imaging, and Contemporary Management, is an open-access publication. Be sure to share it with your colleagues.
The Journal of Nuclear Cardiology has just released a new JNC Compendium that provides a clear, up-to-date summary of what is known about cardiac amyloidosis as well as insights on the future of the field.
Titled Cardiac Amyloidosis: Pathophysiology, Imaging, and Contemporary Management, the compendium “aims to serve as a practical and authoritative resource for imaging specialists, trainees, and clinicians,” says JNC Editor-in-Chief Marcelo F. Di Carli, MD, MASNC.
Dr. Di Carli encourages readers to review the compendium in order because the articles are “intentionally complementary,” sequenced to tell the story of the field’s “rapid transition – one in which imaging has moved from a supportive role to a central position in defining disease, guiding therapy, and facilitating recruitment into clinical trials.”
Compendium at a Glance:
- A New Era in Cardiac Amyloidosis, by Marcelo F. Di Carli, MD, MASNC
- Cardiac Amyloidosis: Disease Overview and Novel Pathophysiologic Insights, by Gregorio Tersalvi, MD, et al
- Cardiac Amyloidosis: Current and Pipeline of Therapies for the Nuclear Imager, by Bryton Davis, MD, MBA, and Ahmad Masri, MD, MS
- The Evolution of Tc-99m-Labeled Cardiac Amyloid Radionuclide Imaging for Transthyretin Cardiomyopathy: Current State-of-the-Art, by Prem Soman, MD, PhD, MASNC, et al
- Quantitative Cardiac Amyloid Radionuclide Imaging, by Robert J.H. Miller, MD, PhD, FASNC, et al
- Multimodality Imaging in Cardiac Amyloidosis: When and How to Combine Nuclear Techniques with Echocardiography and Cardiac Magnetic Resonance Imaging, by Dominik C. Benz, MD, FASNC, and Sarah A.M. Cuddy, MD, FASNC
- An Era of Precision: Emerging, Research, and Adjunct Radiotracers for Nuclear Imaging of Cardiac Amyloidosis, by Jonathan S. Wall, PhD, and Emily B. Martin, PhD
- Cardiac Amyloid Radionuclide Imaging: Global Perspective and Future Priorities, by Firas Al Badarin, MD, MSc, FASNC
To foster innovation, the Journal is offering its latest compendium as an open-access publication. Please share it with your colleagues involved in the diagnosis, treatment, and management of cardiac amyloidosis and with researchers interested in advancing the field.
Article Type
JNC News, News & Announcements
Category
Education, Journal of Nuclear Cardiology (JNC), Publications, Research
Related Posts
Investigational PET Radiotracer Meets Primary Endpoints for Diagnosing Cardiac Amyloidosis
The Phase III REVEAL study met its primary endpoints demonstrating sensitivity and…
New Podcast! Is PET the Key to Finally Getting Heart Disease Diagnoses Right for Women?
Episode 13 of JNC CardioConnect highlights the results of the landmark AURORA…
New Record! ASNC2026 Abstract/Case Submissions Achieve 30% Growth Over 5 Years
“This is an exciting time for all of us in nuclear cardiology,…


